Draft Guidance for Industry and Staff; Availability: Content of Investigational Device Exemption and Premarket Approval Applications for Low Glucose Suspend Device Systems
Document ID: FDA-2011-D-0464-0001
Comments
Total: 28
-
Bennet Rea Dunlap - Comment
Posted : 09/23/2011 ID ：FDA-2011-D-0464-0003 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Michael W. Hoskins - Comment
Posted : 09/23/2011 ID ：FDA-2011-D-0464-0004 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Kelly Norton - Comment
Posted : 09/23/2011 ID ：FDA-2011-D-0464-0005 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Matt James McGuire - Comment
Posted : 09/23/2011 ID ：FDA-2011-D-0464-0006 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Kristin Cameron - Comment
Posted : 09/23/2011 ID ：FDA-2011-D-0464-0007 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Anonymous - Comment
Posted : 09/23/2011 ID ：FDA-2011-D-0464-0008 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Jaeb Center for Health Research - Comment
Posted : 09/23/2011 ID ：FDA-2011-D-0464-0009 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
University of Virginia - Comment
Posted : 09/23/2011 ID ：FDA-2011-D-0464-0010 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Steven Brenner - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0011 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Vincent Carlos Coelho - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0012 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Janice Schacowsky - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0013 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Camille Anne Nash - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0014 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Cecile Clare Foster - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0015 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Olia Marie Yelner - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0016 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Debbie A Evans - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0017 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Keither Scott Creek - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0018 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Advanced Medical Technology Association (AdvaMed) - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0019 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Shelley Jane Page - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0020 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
LaDonna Michelle Verser - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0021 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Juvenile Diabetes Research Foundation (JDRF) - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0022 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Robert S. Sherwin, MD et al - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0023 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Leigh Erin Evans - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0024 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
American Diabetes Association - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0025 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Chuck John Bloch - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0026 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
American Association of Clinical Endocrinologists (AACE) - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0027 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
Judith (Judy) Ann Krtek - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0028 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
American Assocation of Diabetes Educators (AADE) - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0029 Agency : FDA -
Sep 20,2011 11:59 PM ET
-
William Lee Dubois - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0464-0030 Agency : FDA -
Sep 20,2011 11:59 PM ET